Small Intestinal Bacterial Overgrowth and Metabolic Dysfunction-associated Steatotic Liver Disease

Overview

Journal Front Nutr

Specialty Nutritional Sciences

Date 2025 Jan 1

PMID 39742106

Authors

Ziteng Wang

Wentao Tan

Jiali Huang

Qian Li

Jing Wang

Hui Su

Chunmei Guo

Hong Liu

Affiliations

Soon will be listed here.

Abstract

Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=427040.

References

Gomes A, Hoffmann C, Mota J . The human gut microbiota: Metabolism and perspective in obesity. Gut Microbes. 2018; 9(4):308-325. PMC: 6219651. DOI: 10.1080/19490976.2018.1465157. View

Shi H, Mao L, Wang L, Quan X, Xu X, Cheng Y . Small intestinal bacterial overgrowth and orocecal transit time in patients of nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2021; 33(1S Suppl 1):e535-e539. DOI: 10.1097/MEG.0000000000002157. View

Fu C, Teng M, Tung D, Ramadoss V, Ong C, Koh B . Sex and Race-Ethnic Disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease: An Analysis of 40,166 Individuals. Dig Dis Sci. 2024; 69(9):3195-3205. DOI: 10.1007/s10620-024-08540-4. View

Lo C, Mertz D, Loeb M . Newcastle-Ottawa Scale: comparing reviewers' to authors' assessments. BMC Med Res Methodol. 2014; 14:45. PMC: 4021422. DOI: 10.1186/1471-2288-14-45. View

Ochoa-Allemant P, Marrero J, Serper M . Racial and ethnic differences and the role of unfavorable social determinants of health across steatotic liver disease subtypes in the United States. Hepatol Commun. 2023; 7(12). PMC: 10697602. DOI: 10.1097/HC9.0000000000000324. View

Takakura W, Pimentel M . Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome - An Update. Front Psychiatry. 2020; 11:664. PMC: 7366247. DOI: 10.3389/fpsyt.2020.00664. View

Xie D, Zhao H, Lu J, He F, Liu W, Yu W . High uric acid induces liver fat accumulation via ROS/JNK/AP-1 signaling. Am J Physiol Endocrinol Metab. 2021; 320(6):E1032-E1043. DOI: 10.1152/ajpendo.00518.2020. View

Eslam M, Newsome P, Sarin S, Anstee Q, Targher G, Romero-Gomez M . A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol. 2020; 73(1):202-209. DOI: 10.1016/j.jhep.2020.03.039. View

Kapil S, Duseja A, Sharma B, Singla B, Chakraborti A, Das A . Small intestinal bacterial overgrowth and toll-like receptor signaling in patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2015; 31(1):213-21. DOI: 10.1111/jgh.13058. View

10.

Ghoshal U, Baba C, Ghoshal U, Alexander G, Misra A, Saraswat V . Low-grade small intestinal bacterial overgrowth is common in patients with non-alcoholic steatohepatitis on quantitative jejunal aspirate culture. Indian J Gastroenterol. 2017; 36(5):390-399. DOI: 10.1007/s12664-017-0797-6. View

11.

Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal W, Strowig T . Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature. 2012; 482(7384):179-85. PMC: 3276682. DOI: 10.1038/nature10809. View

12.

Bures J, Cyrany J, Kohoutova D, Forstl M, Rejchrt S, Kvetina J . Small intestinal bacterial overgrowth syndrome. World J Gastroenterol. 2010; 16(24):2978-90. PMC: 2890937. DOI: 10.3748/wjg.v16.i24.2978. View

13.

Lo H . Bioactive Components and Possible Activities of Medicinal Mushrooms in Alleviating the Pathogenesis of Nonalcoholic Fatty Liver Disease (Review). Int J Med Mushrooms. 2021; 23(3):29-41. DOI: 10.1615/IntJMedMushrooms.2021037945. View

14.

Al-Dayyat H, Rayyan Y, Tayyem R . Non-alcoholic fatty liver disease and associated dietary and lifestyle risk factors. Diabetes Metab Syndr. 2018; 12(4):569-575. DOI: 10.1016/j.dsx.2018.03.016. View

15.

De Oliveira J, Pace F, Ghetti F, Barbosa K, Cesar D, Chebli J . Non-alcoholic Steatohepatitis: Comparison of Intestinal Microbiota between Different Metabolic Profiles. A Pilot Study. J Gastrointestin Liver Dis. 2020; 29(3):369-376. DOI: 10.15403/jgld-497. View

16.

Rinella M, Lazarus J, Ratziu V, Francque S, Sanyal A, Kanwal F . A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023; 79(6):1542-1556. DOI: 10.1016/j.jhep.2023.06.003. View

17.

Mikolasevic I, Delija B, Mijic A, Stevanovic T, Skenderevic N, Sosa I . Small intestinal bacterial overgrowth and non-alcoholic fatty liver disease diagnosed by transient elastography and liver biopsy. Int J Clin Pract. 2021; 75(4):e13947. DOI: 10.1111/ijcp.13947. View

18.

Gerard P . Gut microbiota and obesity. Cell Mol Life Sci. 2015; 73(1):147-62. PMC: 11108539. DOI: 10.1007/s00018-015-2061-5. View

19.

Hutchison A, Tavaglione F, Romeo S, Charlton M . Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance. J Hepatol. 2023; 79(6):1524-1541. DOI: 10.1016/j.jhep.2023.08.030. View

20.

Martinez-Guryn K, Hubert N, Frazier K, Urlass S, Musch M, Ojeda P . Small Intestine Microbiota Regulate Host Digestive and Absorptive Adaptive Responses to Dietary Lipids. Cell Host Microbe. 2018; 23(4):458-469.e5. PMC: 5912695. DOI: 10.1016/j.chom.2018.03.011. View